Michael Aldridge

Michael Aldridge

Chief Executive Officer presso Advanced Chemotherapy Technologies, Inc.

57 anni
Health Technology
Finance
Consumer Services

Profilo

Michael Douglas Arthur Aldridge was the founder of Sirona Therapeutics Ltd.
founded in 2015, where he held the position of President, Chief Executive Officer & Director.
Currently, he is the Chief Executive Officer at Advanced Chemotherapy Technologies, Inc. since 2022 and a Director at University of Canterbury Foundation In America, Inc. since 2015.
He also served as a Director at Bear, Stearns & Co., Inc. in 2002, Pinnacle Investment Management Group Ltd.
from 2002 to 2003, and Codexis, Inc. from 2016 to 2018.
Additionally, he was an Independent Director at Allon Therapeutics, Inc. from 2012 to 2013.
Mr. Aldridge's education includes a graduate degree from Macquarie University and an undergraduate degree from the University of Canterbury.

Posizioni attive di Michael Aldridge

SocietàPosizioneInizio
University of Canterbury Foundation In America, Inc. Director/Board Member 01/01/2015
Chief Executive Officer 01/11/2022
Tutte le posizioni attive di Michael Aldridge

Precedenti posizioni note di Michael Aldridge

SocietàPosizioneFine
HEXIMA LIMITED Chief Executive Officer 02/08/2022
CODEXIS, INC. Corporate Officer/Principal 17/08/2018
Founder 01/07/2017
QUESTCOR PHARMACEUTICALS INC Corporate Officer/Principal 01/09/2014
ALLON THERAPEUTICS INC. Director/Board Member 30/01/2013
Vedi nel dettaglio l'esperienza di Michael Aldridge

Formazione di Michael Aldridge

Macquarie University Graduate Degree
University of Canterbury Undergraduate Degree

Esperienze
Posizioni ricoperte

Attive

Inattive

Società quotate in Borsa

Aziende private

Vedi nel dettaglio l'esperienza di Michael Aldridge

Relazioni

100 +

Relazioni di 1° grado

15

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Società quotate in Borsa4
CODEXIS, INC.

Process Industries

HEXIMA LIMITED

Health Technology

ALLON THERAPEUTICS INC.

Health Technology

PINNACLE INVESTMENT MANAGEMENT GROUP LIMITED

Finance

Aziende private9

Finance

Health Technology

Health Technology

Volpe Brown Whelan & Co. LLC

Finance

Finance

Health Technology

Health Technology

Health Technology

University of Canterbury Foundation In America, Inc.

Vedi le connessioni aziendali
  1. Borsa valori
  2. Insiders
  3. Michael Aldridge